Novel approaches for targeted sleep apnoea treatment and management [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description >1million Australian adults have obstructive sleep apnoea (OSA). OSA has several causes. Untreated OSA is associated with major health consequences. <50% of OSA patients tolerate the main therapy, continuous positive airway pressure. New treatments are urgently required. This proposal aims to use and develop novel approaches to identify the causes of OSA on a per patient basis, improve current therapies and management approaches and test if new targeted therapies can be used to treat OSA.

Funding Amount $2,090,576

Funding Scheme Investigator Grants

Chief Investigator Prof Danny Eckert

Notes Leadership 1